Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB) (TESEC-04)

This study has been completed.
Information provided by (Responsible Party):
Statens Serum Institut Identifier:
First received: November 15, 2010
Last updated: April 16, 2015
Last verified: April 2015